Technical analysis of Matinas BioPharma Holdings, Inc. (MTNB): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts.
Price Performance
| 1 month | -18.95% |
| 3 months | -72.67% |
| Year-to-date | -71.83% |
| 1 year | -89.99% |
| 3 years | -97.75% |
| 5 years | -99.70% |
52-Week Range
| 52-week High | $2.14 |
| 52-week Low | $0.15 |
| Avg Volume (90d) | 4.0M |
Technical Indicators
| SMA 50 | $0.27 |
| SMA 200 | $0.56 |
| Beta | 1.40 |
| 30-day Volatility (annualised) | 127.7% |
| Price vs SMA 50 | -39.6% |
| Price vs SMA 200 | -70.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.38 | |
| 2025-11 | $0.75 | -45.7% |
| 2025-12 | $0.59 | -21.9% |
| 2026-01 | $0.60 | +2.0% |
| 2026-02 | $0.61 | +1.7% |
| 2026-03 | $0.50 | -17.8% |
| 2026-04 | $0.65 | +30.1% |
| 2026-05 | $0.81 | +24.5% |
| 2026-06 | $0.61 | -24.4% |
| 2026-07 | $0.29 | -52.0% |
| 2026-08 | $0.20 | -32.7% |
| 2026-09 | $0.17 | -16.5% |
Price
| Price | $0.17 |
| Market Cap | $1M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.60 |
| EV / EBITDA | -0.07 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.85 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -42.88 |